|
chr11_+_12695851
|
4.169
|
NM_021961
|
TEAD1
|
TEA domain family member 1 (SV40 transcriptional enhancer factor)
|
|
chr2_-_216300770
|
3.886
|
NM_002026
NM_054034
NM_212474
NM_212476
NM_212478
NM_212482
|
FN1
|
fibronectin 1
|
|
chr20_+_19915716
|
3.516
|
|
RIN2
|
Ras and Rab interactor 2
|
|
chr9_-_99382073
|
3.482
|
NM_003671
NM_033331
|
CDC14B
|
CDC14 cell division cycle 14 homolog B (S. cerevisiae)
|
|
chr1_-_20812727
|
3.191
|
NM_018584
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1
|
|
chr19_+_16187266
|
2.970
|
|
TPM4
|
tropomyosin 4
|
|
chr19_+_16187315
|
2.938
|
|
TPM4
|
tropomyosin 4
|
|
chr3_-_99594915
|
2.657
|
NM_014890
|
FILIP1L
|
filamin A interacting protein 1-like
|
|
chr3_+_8543508
|
2.617
|
NM_014583
|
LMCD1
|
LIM and cysteine-rich domains 1
|
|
chr21_-_44846927
|
2.350
|
NM_173354
|
SIK1
|
salt-inducible kinase 1
|
|
chr11_+_117070039
|
2.344
|
NM_001001522
NM_003186
|
TAGLN
|
transgelin
|
|
chr6_+_139456240
|
2.299
|
NM_016217
|
HECA
|
headcase homolog (Drosophila)
|
|
chr2_-_238322770
|
2.149
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr19_+_16187306
|
2.118
|
|
TPM4
|
tropomyosin 4
|
|
chr2_-_238322840
|
2.066
|
NM_004369
NM_057164
NM_057165
NM_057166
NM_057167
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr4_-_186456580
|
1.993
|
NM_001114107
NM_014476
|
PDLIM3
|
PDZ and LIM domain 3
|
|
chr8_-_18666295
|
1.979
|
NM_206909
|
PSD3
|
pleckstrin and Sec7 domain containing 3
|
|
chr5_-_172198160
|
1.939
|
NM_004417
|
DUSP1
|
dual specificity phosphatase 1
|
|
chr3_+_8543539
|
1.920
|
|
LMCD1
|
LIM and cysteine-rich domains 1
|
|
chr11_+_69455938
|
1.841
|
|
CCND1
|
cyclin D1
|
|
chr11_+_69455837
|
1.840
|
NM_053056
|
CCND1
|
cyclin D1
|
|
chr4_-_111558150
|
1.839
|
|
PITX2
|
paired-like homeodomain 2
|
|
chr1_-_59249687
|
1.737
|
NM_002228
|
JUN
|
jun proto-oncogene
|
|
chr19_+_45349560
|
1.731
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr11_-_111782447
|
1.699
|
NM_001885
|
CRYAB
|
crystallin, alpha B
|
|
chr1_-_1293907
|
1.688
|
NM_032348
|
MXRA8
|
matrix-remodelling associated 8
|
|
chr2_-_216300444
|
1.687
|
|
FN1
|
fibronectin 1
|
|
chr3_+_187871473
|
1.661
|
NM_001167672
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
chr2_-_238322815
|
1.660
|
|
COL6A3
|
collagen, type VI, alpha 3
|
|
chr7_+_134464417
|
1.631
|
|
CALD1
|
caldesmon 1
|
|
chr13_-_110802708
|
1.620
|
|
COL4A1
|
collagen, type IV, alpha 1
|
|
chr3_-_187463474
|
1.577
|
NM_001706
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr1_+_99730067
|
1.567
|
|
LPPR4
|
lipid phosphate phosphatase-related protein type 4
|
|
chr21_+_47545189
|
1.547
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
chr10_+_63808968
|
1.545
|
NM_001244638
|
ARID5B
|
AT rich interactive domain 5B (MRF1-like)
|
|
chr17_+_41476351
|
1.524
|
NM_001661
|
ARL4D
|
ADP-ribosylation factor-like 4D
|
|
chr16_-_10674443
|
1.507
|
NM_001424
|
EMP2
|
epithelial membrane protein 2
|
|
chr6_+_39760148
|
1.468
|
NM_001201427
|
DAAM2
|
dishevelled associated activator of morphogenesis 2
|
|
chr21_+_47545896
|
1.444
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
chr8_-_42065037
|
1.437
|
|
PLAT
|
plasminogen activator, tissue
|
|
chr11_-_35547144
|
1.418
|
NM_001001991
NM_015430
|
PAMR1
|
peptidase domain containing associated with muscle regeneration 1
|
|
chr6_-_169653922
|
1.404
|
|
THBS2
|
thrombospondin 2
|
|
chr8_-_42065193
|
1.381
|
NM_000930
NM_033011
|
PLAT
|
plasminogen activator, tissue
|
|
chr19_-_52227220
|
1.369
|
NM_001523
|
HAS1
|
hyaluronan synthase 1
|
|
chr2_-_211168315
|
1.353
|
NM_079422
|
MYL1
|
myosin, light chain 1, alkali; skeletal, fast
|
|
chr3_+_158991035
|
1.338
|
NM_001197107
NM_001197108
NM_014575
|
SCHIP1
|
schwannomin interacting protein 1
|
|
chr2_+_28615695
|
1.327
|
|
FOSL2
|
FOS-like antigen 2
|
|
chr2_+_220283098
|
1.327
|
NM_001927
|
DES
|
desmin
|
|
chr8_-_119123804
|
1.293
|
NM_000127
|
EXT1
|
exostosin 1
|
|
chr8_+_94929082
|
1.287
|
NM_018444
NM_001161780
NM_001161779
NM_001161781
|
PDP1
|
pyruvate dehyrogenase phosphatase catalytic subunit 1
|
|
chr11_+_129939807
|
1.269
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr1_-_193155723
|
1.261
|
NM_003783
|
B3GALT2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2
|
|
chr22_+_38597938
|
1.253
|
NM_001161572
NM_001161574
NM_012323
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr5_-_57755787
|
1.251
|
NM_001252226
NM_006622
|
PLK2
|
polo-like kinase 2
|
|
chr3_+_100211554
|
1.227
|
|
TMEM45A
|
transmembrane protein 45A
|
|
chr10_-_99446899
|
1.220
|
NM_021732
|
AVPI1
|
arginine vasopressin-induced 1
|
|
chr11_+_129939792
|
1.214
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr9_+_97488943
|
1.199
|
NM_001193331
NM_032823
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr14_+_104095491
|
1.196
|
NM_001130107
NM_005552
NM_182923
|
KLC1
|
kinesin light chain 1
|
|
chr16_-_79634610
|
1.189
|
NM_001031804
NM_005360
|
MAF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian)
|
|
chr9_+_97488993
|
1.170
|
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr12_+_13044352
|
1.168
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
|
chr10_-_62703822
|
1.168
|
NM_001242359
NM_014836
|
RHOBTB1
|
Rho-related BTB domain containing 1
|
|
chr4_-_111544206
|
1.161
|
NM_000325
|
PITX2
|
paired-like homeodomain 2
|
|
chr22_+_38598065
|
1.155
|
|
MAFF
|
v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)
|
|
chr3_+_62304667
|
1.134
|
|
C3orf14
|
chromosome 3 open reading frame 14
|
|
chr9_+_97521930
|
1.129
|
NM_001193329
|
C9orf3
|
chromosome 9 open reading frame 3
|
|
chr5_+_34687663
|
1.103
|
NM_001145523
|
RAI14
|
retinoic acid induced 14
|
|
chr11_+_69455978
|
1.098
|
|
CCND1
|
cyclin D1
|
|
chr2_+_241375030
|
1.088
|
NM_002081
|
GPC1
|
glypican 1
|
|
chr5_-_131562934
|
1.078
|
NM_001017973
NM_004199
|
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II
|
|
chr7_+_65670256
|
1.070
|
NM_003596
|
TPST1
|
tyrosylprotein sulfotransferase 1
|
|
chrX_-_13835187
|
1.065
|
|
GPM6B
|
glycoprotein M6B
|
|
chr4_+_668250
|
1.065
|
|
MYL5
|
myosin, light chain 5, regulatory
|
|
chr11_+_129939847
|
1.061
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr1_-_110933635
|
1.059
|
|
SLC16A4
|
solute carrier family 16, member 4 (monocarboxylic acid transporter 5)
|
|
chr2_-_86850935
|
1.054
|
|
RNF103
|
ring finger protein 103
|
|
chr2_+_232457574
|
1.050
|
NM_152614
|
C2orf57
|
chromosome 2 open reading frame 57
|
|
chr4_+_668312
|
1.041
|
|
MYL5
|
myosin, light chain 5, regulatory
|
|
chr19_-_9695166
|
1.034
|
NM_001008727
|
ZNF121
|
zinc finger protein 121
|
|
chr7_-_129592794
|
1.033
|
NM_003344
NM_182697
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
|
chr11_+_129939787
|
1.031
|
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr5_+_52776479
|
1.031
|
|
FST
|
follistatin
|
|
chr1_-_16482426
|
1.022
|
NM_004431
|
EPHA2
|
EPH receptor A2
|
|
chr17_+_66508564
|
1.020
|
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
|
chr12_+_13044493
|
1.020
|
|
GPRC5A
|
G protein-coupled receptor, family C, group 5, member A
|
|
chr10_+_123923104
|
1.011
|
NM_006997
NM_206860
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr10_+_102792166
|
1.005
|
|
SFXN3
|
sideroflexin 3
|
|
chr2_-_86850959
|
0.999
|
NM_001198951
NM_001198952
NM_005667
|
RNF103
|
ring finger protein 103
|
|
chr5_+_71403040
|
0.985
|
NM_005909
|
MAP1B
|
microtubule-associated protein 1B
|
|
chr2_+_5832778
|
0.981
|
NM_003108
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
chr16_+_31119748
|
0.972
|
|
BCKDK
|
branched chain ketoacid dehydrogenase kinase
|
|
chr8_-_18541441
|
0.967
|
|
PSD3
|
pleckstrin and Sec7 domain containing 3
|
|
chr5_+_71502700
|
0.963
|
|
MAP1B
|
microtubule-associated protein 1B
|
|
chr17_-_13505217
|
0.959
|
NM_006042
|
HS3ST3A1
|
heparan sulfate (glucosamine) 3-O-sulfotransferase 3A1
|
|
chr6_-_128841432
|
0.947
|
NM_002844
NM_001135648
|
PTPRK
|
protein tyrosine phosphatase, receptor type, K
|
|
chr9_-_14086901
|
0.944
|
|
NFIB
|
nuclear factor I/B
|
|
chr1_-_110933683
|
0.939
|
NM_001201546
NM_001201547
NM_001201548
NM_001201549
NM_004696
|
SLC16A4
|
solute carrier family 16, member 4 (monocarboxylic acid transporter 5)
|
|
chr10_+_124134206
|
0.938
|
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
chr16_+_86544104
|
0.935
|
NM_001451
|
FOXF1
|
forkhead box F1
|
|
chr16_+_31119730
|
0.933
|
|
BCKDK
|
branched chain ketoacid dehydrogenase kinase
|
|
chr10_+_123922940
|
0.929
|
|
TACC2
|
transforming, acidic coiled-coil containing protein 2
|
|
chr9_-_129884885
|
0.926
|
|
ANGPTL2
|
angiopoietin-like 2
|
|
chr12_-_102455793
|
0.925
|
NM_016053
|
CCDC53
|
coiled-coil domain containing 53
|
|
chr12_+_10365415
|
0.916
|
NM_031412
|
GABARAPL1
|
GABA(A) receptor-associated protein like 1
|
|
chr10_+_102792161
|
0.915
|
|
SFXN3
|
sideroflexin 3
|
|
chr14_+_88851987
|
0.915
|
NM_001040428
NM_018418
|
SPATA7
|
spermatogenesis associated 7
|
|
chrX_-_13956530
|
0.909
|
|
GPM6B
|
glycoprotein M6B
|
|
chr14_+_101292483
|
0.904
|
|
|
|
|
chr6_-_46293628
|
0.903
|
NM_005822
|
RCAN2
|
regulator of calcineurin 2
|
|
chr5_+_138211084
|
0.901
|
|
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa
|
|
chr18_-_21891469
|
0.896
|
NM_001242508
|
OSBPL1A
|
oxysterol binding protein-like 1A
|
|
chr13_+_48807492
|
0.889
|
|
ITM2B
|
integral membrane protein 2B
|
|
chr18_+_8717368
|
0.880
|
NM_015210
|
CCDC165
|
coiled-coil domain containing 165
|
|
chr22_-_44258210
|
0.879
|
NM_014351
|
SULT4A1
|
sulfotransferase family 4A, member 1
|
|
chr10_+_124134093
|
0.878
|
NM_001001974
|
PLEKHA1
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1
|
|
chr6_+_148663728
|
0.878
|
NM_015278
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr2_+_30454396
|
0.876
|
NM_030915
|
LBH
|
limb bud and heart development homolog (mouse)
|
|
chr19_+_45349584
|
0.865
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
chr3_+_9975513
|
0.863
|
NM_015513
NM_001031717
NM_001077415
|
CRELD1
|
cysteine-rich with EGF-like domains 1
|
|
chr11_-_2159472
|
0.862
|
|
IGF2
|
insulin-like growth factor 2 (somatomedin A)
|
|
chr9_+_33624214
|
0.861
|
|
ANXA2P2
|
annexin A2 pseudogene 2
|
|
chrX_-_10645726
|
0.856
|
NM_001098624
|
MID1
|
midline 1 (Opitz/BBB syndrome)
|
|
chr6_+_148664124
|
0.855
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr6_+_148663953
|
0.853
|
|
SASH1
|
SAM and SH3 domain containing 1
|
|
chr12_+_54378929
|
0.851
|
NM_017409
|
HOXC10
|
homeobox C10
|
|
chr11_+_129939667
|
0.849
|
NM_001142276
NM_001142277
NM_001142278
NM_001642
|
APLP2
|
amyloid beta (A4) precursor-like protein 2
|
|
chr17_-_63822660
|
0.843
|
NM_001037325
|
CEP112
|
centrosomal protein 112kDa
|
|
chr8_-_98290072
|
0.842
|
|
TSPYL5
|
TSPY-like 5
|
|
chr7_-_129592711
|
0.841
|
NM_001202498
|
UBE2H
|
ubiquitin-conjugating enzyme E2H
|
|
chr3_+_171757432
|
0.839
|
|
FNDC3B
|
fibronectin type III domain containing 3B
|
|
chr3_-_187463227
|
0.835
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
chr3_-_10067989
|
0.832
|
|
CIDECP
|
cell death-inducing DFFA-like effector c pseudogene
|
|
chr9_-_129884998
|
0.831
|
NM_012098
|
ANGPTL2
|
angiopoietin-like 2
|
|
chr15_-_35087748
|
0.818
|
NM_005159
|
ACTC1
|
actin, alpha, cardiac muscle 1
|
|
chr12_+_122150638
|
0.816
|
NM_001080825
|
TMEM120B
|
transmembrane protein 120B
|
|
chr2_+_33172368
|
0.813
|
NM_206943
|
LTBP1
|
latent transforming growth factor beta binding protein 1
|
|
chr3_+_154797435
|
0.812
|
NM_000902
|
MME
|
membrane metallo-endopeptidase
|
|
chr1_-_235812994
|
0.803
|
NM_001098722
|
GNG4
|
guanine nucleotide binding protein (G protein), gamma 4
|
|
chr12_-_102455763
|
0.799
|
|
CCDC53
|
coiled-coil domain containing 53
|
|
chr9_+_112887780
|
0.796
|
NM_001136562
|
AKAP2
|
A kinase (PRKA) anchor protein 2
|
|
chr11_-_63381907
|
0.794
|
NM_007069
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr21_-_45079327
|
0.788
|
NM_007031
|
HSF2BP
|
heat shock transcription factor 2 binding protein
|
|
chr8_+_98788014
|
0.774
|
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
chr11_-_63381840
|
0.768
|
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr21_+_47546427
|
0.764
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
chr1_+_78470593
|
0.764
|
NM_007034
|
DNAJB4
|
DnaJ (Hsp40) homolog, subfamily B, member 4
|
|
chr14_+_101292451
|
0.763
|
|
MEG3
|
maternally expressed 3 (non-protein coding)
|
|
chr1_+_99729847
|
0.762
|
NM_001166252
NM_014839
|
LPPR4
|
lipid phosphate phosphatase-related protein type 4
|
|
chr1_+_160175146
|
0.762
|
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
chr14_+_88852065
|
0.755
|
|
SPATA7
|
spermatogenesis associated 7
|
|
chr1_-_201475966
|
0.755
|
NM_001193571
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr1_-_201476241
|
0.749
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr11_-_119187811
|
0.747
|
NM_006500
|
MCAM
|
melanoma cell adhesion molecule
|
|
chrX_-_13956644
|
0.747
|
NM_001001994
|
GPM6B
|
glycoprotein M6B
|
|
chr6_-_46293404
|
0.742
|
|
RCAN2
|
regulator of calcineurin 2
|
|
chr1_-_201476218
|
0.739
|
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr8_+_26240522
|
0.738
|
NM_004331
|
BNIP3L
|
BCL2/adenovirus E1B 19kDa interacting protein 3-like
|
|
chr3_+_11267666
|
0.737
|
NM_001098211
|
HRH1
|
histamine receptor H1
|
|
chr1_+_160175114
|
0.731
|
NM_003768
|
PEA15
|
phosphoprotein enriched in astrocytes 15
|
|
chr1_-_201476248
|
0.728
|
NM_001193570
NM_004078
|
CSRP1
|
cysteine and glycine-rich protein 1
|
|
chr11_+_69455884
|
0.723
|
|
CCND1
|
cyclin D1
|
|
chr1_-_95392501
|
0.720
|
NM_001839
|
CNN3
|
calponin 3, acidic
|
|
chr8_-_98290171
|
0.720
|
NM_033512
|
TSPYL5
|
TSPY-like 5
|
|
chr17_+_66508525
|
0.720
|
NM_002734
NM_212472
|
PRKAR1A
|
protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)
|
|
chr11_-_63381940
|
0.713
|
NM_001128203
|
PLA2G16
|
phospholipase A2, group XVI
|
|
chr4_-_156297944
|
0.705
|
|
MAP9
|
microtubule-associated protein 9
|
|
chr9_+_34990266
|
0.705
|
NM_001135005
|
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5
|
|
chr21_+_35190586
|
0.704
|
|
ITSN1
|
intersectin 1 (SH3 domain protein)
|
|
chr2_+_131862885
|
0.703
|
|
PLEKHB2
|
pleckstrin homology domain containing, family B (evectins) member 2
|
|
chr8_-_49833823
|
0.686
|
NM_003068
|
SNAI2
|
snail homolog 2 (Drosophila)
|
|
chrX_-_68385249
|
0.678
|
NM_001032396
NM_022368
NM_145119
|
PJA1
|
praja ring finger 1
|
|
chr3_-_124774735
|
0.677
|
NM_020733
|
HEG1
|
HEG homolog 1 (zebrafish)
|
|
chr8_+_98787808
|
0.673
|
NM_018407
|
LAPTM4B
|
lysosomal protein transmembrane 4 beta
|
|
chr11_-_8832189
|
0.671
|
NM_213618
|
ST5
|
suppression of tumorigenicity 5
|
|
chr11_-_27723061
|
0.671
|
NM_170733
|
BDNF
|
brain-derived neurotrophic factor
|
|
chr12_+_56552141
|
0.664
|
|
MYL6
|
myosin, light chain 6, alkali, smooth muscle and non-muscle
|
|
chr3_-_107941168
|
0.662
|
NM_018010
|
IFT57
|
intraflagellar transport 57 homolog (Chlamydomonas)
|
|
chr2_+_54785453
|
0.661
|
NM_178313
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
chr4_-_170924911
|
0.654
|
NM_001009554
|
MFAP3L
|
microfibrillar-associated protein 3-like
|
|
chr1_+_25071906
|
0.653
|
|
CLIC4
|
chloride intracellular channel 4
|
|
chr2_+_28615668
|
0.651
|
|
FOSL2
|
FOS-like antigen 2
|
|
chr2_-_224467095
|
0.651
|
|
SCG2
|
secretogranin II
|
|
chr8_-_18871163
|
0.651
|
NM_015310
|
PSD3
|
pleckstrin and Sec7 domain containing 3
|
|
chr7_-_37956377
|
0.649
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
chr2_-_224467142
|
0.646
|
NM_003469
|
SCG2
|
secretogranin II
|
|
chrX_-_13835012
|
0.645
|
|
GPM6B
|
glycoprotein M6B
|
|
chr4_-_156297973
|
0.639
|
|
MAP9
|
microtubule-associated protein 9
|
|
chr12_-_102455739
|
0.638
|
|
CCDC53
|
coiled-coil domain containing 53
|
|
chr22_+_44319674
|
0.634
|
|
PNPLA3
|
patatin-like phospholipase domain containing 3
|
|
chr6_-_47277511
|
0.633
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr6_-_47277646
|
0.630
|
NM_014452
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr13_-_52980628
|
0.629
|
NM_018676
NM_199263
|
THSD1
|
thrombospondin, type I, domain containing 1
|
|
chr17_+_53342356
|
0.625
|
|
HLF
|
hepatic leukemia factor
|
|
chr19_+_16187047
|
0.623
|
NM_003290
|
TPM4
|
tropomyosin 4
|
|
chr2_+_46524448
|
0.610
|
NM_001430
|
EPAS1
|
endothelial PAS domain protein 1
|
|
chr19_-_36246411
|
0.610
|
|
HSPB6
|
heat shock protein, alpha-crystallin-related, B6
|
|
chr19_-_46088084
|
0.609
|
NM_001017989
NM_025136
|
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia)
|
|
chr6_-_47277354
|
0.600
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
chr20_+_19870209
|
0.599
|
NM_018993
|
RIN2
|
Ras and Rab interactor 2
|
